Teresa Mc Carthy Avidity Biosciences, Inc. (RNA) insider trading activity

Teresa Mc Carthy is Chief Human Resources Officer of Avidity Biosciences, Inc.. Currently has a direct ownership of 97,130 shares of RNA, which is worth approximately $2.85 Million. The most recent transaction as insider was on Mar 20, 2025, when has been sold 7,778 shares (Common Stock) at a price of $31.06 per share, resulting in proceeds of $241,584. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97.1K

0% 3M change

201.92% 12M change

Total Value Held $2.85 Million

Teresa McCarthy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 20 2025	SELL Open market or private sale	$241,584 $31.06 p/Share	7,778 Reduced 7.41%	97,130 Common Stock
Jan 21 2025	SELL Open market or private sale	$84,627 $28.6 p/Share	2,959 Reduced 2.74%	104,908 Common Stock
Jan 06 2025	BUY Grant, award, or other acquisition	-	25,000 Added 18.82%	107,867 Common Stock
Dec 18 2024	SELL Open market or private sale	$364,191 $32.66 p/Share	11,151 Reduced 11.86%	82,867 Common Stock
Dec 16 2024	SELL Open market or private sale	$831,500 $33.26 p/Share	25,000 Reduced 21.01%	94,018 Common Stock
Dec 16 2024	BUY Exercise of conversion of derivative security	$355,500 $14.22 p/Share	25,000 Added 17.36%	119,018 Common Stock
Nov 18 2024	SELL Open market or private sale	$1,028,500 $41.14 p/Share	25,000 Reduced 21.01%	94,018 Common Stock
Nov 18 2024	BUY Exercise of conversion of derivative security	$355,500 $14.22 p/Share	25,000 Added 17.36%	119,018 Common Stock
Oct 16 2024	SELL Open market or private sale	$1,213,000 $48.52 p/Share	25,000 Reduced 21.01%	94,018 Common Stock
Oct 16 2024	BUY Exercise of conversion of derivative security	$355,500 $14.22 p/Share	25,000 Added 17.36%	119,018 Common Stock
Sep 23 2024	SELL Open market or private sale	$578,732 $44.0 p/Share	13,153 Reduced 16.01%	69,018 Common Stock
Sep 19 2024	BUY Grant, award, or other acquisition	-	50,000 Added 34.72%	94,018 Common Stock
Sep 11 2024	SELL Open market or private sale	$1,010,000 $40.4 p/Share	25,000 Reduced 30.42%	57,171 Common Stock
Sep 11 2024	BUY Exercise of conversion of derivative security	$355,500 $14.22 p/Share	25,000 Added 23.33%	82,171 Common Stock
Jun 18 2024	SELL Open market or private sale	$385,978 $39.13 p/Share	9,864 Reduced 23.47%	32,171 Common Stock
Jun 17 2024	BUY Grant, award, or other acquisition	-	50,000 Added 46.65%	57,171 Common Stock
Jan 22 2024	SELL Open market or private sale	$20,918 $10.13 p/Share	2,065 Reduced 10.81%	17,035 Common Stock
Jan 20 2024	BUY Grant, award, or other acquisition	-	16,500 Added 48.59%	17,458 Common Stock
Jan 20 2023	BUY Grant, award, or other acquisition	-	20,000 Added 48.83%	20,958 Common Stock

Teresa Mc Carthy

Chief Human Resources Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Value

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Avidity Biosciences, Inc.

Track Activities on RNA

Account